BridGene Biosciences, Inc., a biotechnology company using a proprietary chemoproteomics technology to discover and develop small molecules for high-value, traditionally undruggable targets,...

This workflow revolutionizes immunotherapy research and development by comprehensively profiling single T cells to correlate polyfunctionality with cytotoxicity and recovery of those same cells...

- Data to be presented at American Association for Cancer Research (AACR) Annual Meeting 2023 - MARLBOROUGH, Mass., April 17, 2023 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a...

Bringing together Bio-Techne's gold standard RNAscope™ technology with Lunaphore's multiplex sequential immunofluorescence (seqIF™) COMET™ system to develop a best-in-class end-to-end...

Latest Small Molecule to Emerge from GPR65 Discovery Program Counteracts Immunosuppressive Polarization of Macrophages Triggered by an Acidic Tumor Microenvironment (TME) Drives Infiltration of T...

West event hosted in Lake Havasu in April and hosted in Lake of the Ozarks in the summer. LAKE HAVASU CITY, Ariz., April 17, 2023 /PRNewswire/ -- Super Cat Fest (SCF) is embarking on its 14th year...

Walks aim to raise $1 million to support the growing number of people with hearing loss ROCKVILLE, Md., April 17, 2023 /PRNewswire/ -- The Hearing Loss Association of America (HLAA)—the leading...

Vision Media, entertainment's trusted streaming, awards, and marketing partner, announced today that it is debuting a new free secure screening offering. With 36+ years of experience building...

Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that a poster entitled 'A triple...

Kia's 'Opposites United' design philosophy to be showcased in global design exhibition Event takes place from 17th to 23rd April at the Museo della Permanente in Milan, Italy Key Kia designers...